Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Dexibuprofen in Healthy Volunteers
NCT02956525Phase 1Completed
- Sponsor
- Apsen Farmacêutica
- Start
- Apr 2018
- Primary completion
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of dexibuprofen (2 arms), sponsored by Apsen Farmacêutica. Primary endpoint: Incidence and classification of adverse events at 40 days. Started Apr 2018; status: completed.
02
Drugs
dexibuprofen
Beyond the preview
Go deeper on NCT02956525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02956525.